Compare Hims and Hers Health Inc (HIMS) vs Invesco NASDAQ 100 ETF (QQQM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hims and Hers Health Inc vs Invesco NASDAQ 100 ETF — how do they compare? Hims and Hers Health Inc trades at $30.92 (market cap $6.55B), while Invesco NASDAQ 100 ETF trades at $309.39 (market cap $113.40B). The key difference: Invesco NASDAQ 100 ETF is far larger — about 17.3× Hims and Hers Health Inc's market cap, and Invesco NASDAQ 100 ETF is trading nearer its 52-week high, Hims and Hers Health Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hims and Hers Health Inc for 21 Days and Invesco NASDAQ 100 ETF for 54 Days on average.
| HIMS | QQQM | |
|---|---|---|
Market Cap | $6.55B | $113.40B |
Volume | 14,842,814 | 2,866,236 |
Sector | Health | Broad Market / Factor |
52-Week High | $62.76 | $312.76 |
52-Week Low | $14.52 | $229.87 |
Typical Hold Time | 21 Days | 54 Days |
Enterprise Value | $7.25B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HIMS stock trades at $28.06, down 5.01% on the day, reflecting bearish technical signals and negative earnings surprises in recent quarters. The company reported strong revenue growth to $2.35 billion in 2025 but swung to a net loss of -$142 million in 2026, with profitability metrics deteriorating. Multiple securities class action lawsuits filed in October 2026 create significant legal overhangs, while analyst consensus remains cautiously optimistic with a $32.17 price target despite mixed fundamental performance.
The outlook is clouded by legal risks and profitability challenges, though the 15% upside to consensus target suggests potential recovery if execution improves. Key risks include ongoing litigation outcomes and the company's ability to return to sustainable profitability amid competitive pressures in the telehealth sector.
QQQM trades at $307.85, down 1.33% on the day, with a bullish technical outlook supported by moving averages. The ETF benefits from Nasdaq-100 exposure and a competitive 0.15% expense ratio. Recent institutional buying includes QRG Capital Management increasing its position by 207.5% in Q2 2026. Technical indicators show support at $305 and resistance at $311.
The outlook remains positive given Nasdaq-100 strength and lower fees than QQQ. Risks include market concentration in technology stocks and potential tax implications of distributions. Analyst sentiment favors QQQM for core growth allocations, though some prefer equal-weight alternatives for diversification.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →About Invesco NASDAQ 100 ETF
QQQM is an ETF designed to track the performance of the NASDAQ-100 Index. It provides exposure to the 100 largest non-financial companies listed on the NASDAQ. Positioned as a lower-cost and more long-term-investor-friendly alternative to its peer QQQ, QQQM offers the same fundamental market exposure but typically has a lower share price and is structured to appeal to investors focused on accumulation rather than active trading.
Read more on QQQM →
